<document id="DDI-DrugBank.d20">
    <sentence id="DDI-DrugBank.d20.s5" text="Rates of patients with maximum potassium levels  5.5 mEq/L were similar regardless of the use of ACEI/ARB.">
        <entity charOffset="97-100" id="DDI-DrugBank.d20.s5.e0" text="ACEI" type="group" />
        <entity charOffset="102-104" id="DDI-DrugBank.d20.s5.e1" text="ARB" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d20.s5.e0" e2="DDI-DrugBank.d20.s5.e1" id="DDI-DrugBank.d20.s5.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d20.s11" text="The administration of other potassium-sparing antihypertensives with NSAIDs has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.">
        <entity charOffset="28-62" id="DDI-DrugBank.d20.s11.e0" text="potassium-sparing antihypertensives" type="group" />
        <entity charOffset="69-74" id="DDI-DrugBank.d20.s11.e1" text="NSAIDs" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d20.s11.e0" e2="DDI-DrugBank.d20.s11.e1" id="DDI-DrugBank.d20.s11.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d20.s12" text="Therefore, when INSPRA and NSAIDs are used concomitantly, patients should be observed to determine whether the desired effect on blood pressure is obtained.">
        <entity charOffset="16-21" id="DDI-DrugBank.d20.s12.e0" text="INSPRA" type="brand" />
        <entity charOffset="27-32" id="DDI-DrugBank.d20.s12.e1" text="NSAIDs" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d20.s12.e0" e2="DDI-DrugBank.d20.s12.e1" id="DDI-DrugBank.d20.s12.p0" type="advise" />
    </sentence>
</document>